Article
Gene expression profiles of tumor biology provide a novel approach to prognosis and may guide the selection of therapeutic targets in multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Sept 2009
Anguiano Ariel, Tuchman Sascha A, Acharya Chaitanya, Salter Kelly, Gasparetto Cristina, Zhan Fenghuang, Dhodapkar Madhav, Nevins Joseph, Barlogie Bart, Shaughnessy John D, Potti Anil
Abstract excerpt
PURPOSE: Monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) comprise heterogeneous disorders with incompletely understood molecular defects and variable clinical features. We performed gene expression profiling (GEP) with microarray data to better dissect the molecular phenotypes, sensitivity to particular chemotherapeutic agents, and prognoses of these diseases. METHODS: Using...
Topics
- Adult
- Aged
- Antineoplastic Agents
- Biomarkers, Tumor
- Chromosomal Instability
- Cluster Analysis
- Databases as Topic
- Disease-Free Survival
- Female
